Cladribine (Mavenclad): new advice to minimise risk of serious liver injury

2022-03-15T14:31:13+00:00

Liver monitoring requirements for cladribine in the treatment of multiple sclerosis have been introduced following uncommon cases of serious liver injury. Advise patients to seek urgent medical attention if they develop any …